Gina Vaccaro1, Charles D Lopez1. Show Affiliations » 1. Knight Cancer Institute, Brenden-Colson Center for Pancreatic Care, Division of Hematology and Medical Oncology, Department of Medicine, Oregon Health & Science University, Portland, Oregon.
Abstract
Entities: Disease
Mesh： See more » Chemoradiotherapy/adverse effectsDeoxycytidine/administration & dosageDeoxycytidine/adverse effectsDeoxycytidine/analogs & derivativesDose Fractionation, RadiationDrug Administration ScheduleErlotinib Hydrochloride/administration & dosageErlotinib Hydrochloride/adverse effectsFemaleHumansMaleMiddle AgedMortalityPancreatic Neoplasms/mortalityPancreatic Neoplasms/therapySurvival AnalysisTreatment Outcome
Substances： See more » DeoxycytidinegemcitabineErlotinib Hydrochloride
Year: 2017 PMID： 27490715 DOI： 10.1001/jamaoncol.2016.3012
Source DB: PubMed Journal: JAMA Oncol ISSN： 2374-2437 Impact factor: 31.777